AKT1 and cancer: In this study, cancer cell lines showing sensitivity to gefitinib exhibited more phosphorylation of Akt and EGFR without ligand stimulationthan gefitinib-resistant cell lines (Mann-Whitney test:P = 0.0016, P = 0.0274, respectively).